TD Cowen New Analyst on Zimmer Biomet (ZBH) at Buy: 'The Decks Are Clearing'
Tweet Send to a Friend
TD Cowen analyst Matthew Blackman assumes coverage on Zimmer Biomet (NYSE: ZBH) with a Buy rating and a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
